{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Severe hypertriglyceridaemia",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_fibrates",
          "name": "Fibrates"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_omega_3_fatty_acids",
          "name": "Omega-3 fatty acids"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_statins",
          "name": "Statins"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_ezetimibe",
          "name": "Ezetimibe"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_insulin",
          "name": "Insulin"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_lipid_lowering_agents",
          "name": "Lipid-lowering agents"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_oral_hypoglycemics",
          "name": "Oral hypoglycemics"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_metformin",
          "name": "Metformin"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_gemfibrozil",
          "name": "Gemfibrozil"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_atorvastatin",
          "name": "Atorvastatin"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_fibrate",
          "type": "Drug",
          "label": "Fibrates",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_niacin",
          "type": "Drug",
          "label": "Niacin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_omega_3",
          "type": "Drug",
          "label": "Omega-3 fatty acids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_statin",
          "type": "Drug",
          "label": "Statins",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ezetimibe",
          "type": "Drug",
          "label": "Ezetimibe",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_insulin",
          "type": "Drug",
          "label": "Insulin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_lipid_lowering",
          "type": "Drug",
          "label": "Lipid-lowering agents",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_oral_hypoglycemics",
          "type": "Drug",
          "label": "Oral hypoglycemics",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_metformin",
          "type": "Drug",
          "label": "Metformin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_gemfibrozil",
          "type": "Drug",
          "label": "Gemfibrozil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_fenofibrate",
          "type": "Drug",
          "label": "Fenofibrate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_atorvastatin",
          "type": "Drug",
          "label": "Atorvastatin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adverse_phenotype",
          "type": "Phenotype",
          "label": "Potential Adverse Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_risk_pathway",
          "type": "Pathway",
          "label": "Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "n_fibrate",
          "target": "n_risk_pathway",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "潜在的不良效应可能通过风险通路实现"
        },
        {
          "source": "n_niacin",
          "target": "n_risk_pathway",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "潜在的不良效应可能通过风险通路实现"
        },
        {
          "source": "n_omega_3",
          "target": "n_risk_pathway",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的不良效应可能通过风险通路实现"
        },
        {
          "source": "n_statin",
          "target": "n_risk_pathway",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的不良效应可能通过风险通路实现"
        },
        {
          "source": "n_ezetimibe",
          "target": "n_risk_pathway",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的不良效应可能通过风险通路实现"
        },
        {
          "source": "n_insulin",
          "target": "n_risk_pathway",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在的不良效应可能通过风险通路实现"
        },
        {
          "source": "n_lipid_lowering",
          "target": "n_risk_pathway",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在的不良效应可能通过风险通路实现"
        },
        {
          "source": "n_oral_hypoglycemics",
          "target": "n_risk_pathway",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在的不良效应可能通过风险通路实现"
        },
        {
          "source": "n_metformin",
          "target": "n_risk_pathway",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在的不良效应可能通过风险通路实现"
        },
        {
          "source": "n_gemfibrozil",
          "target": "n_risk_pathway",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在的不良效应可能通过风险通路实现"
        },
        {
          "source": "n_fenofibrate",
          "target": "n_risk_pathway",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在的不良效应可能通过风险通路实现"
        },
        {
          "source": "n_atorvastatin",
          "target": "n_risk_pathway",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在的不良效应可能通过风险通路实现"
        },
        {
          "source": "n_risk_pathway",
          "target": "n_adverse_phenotype",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "导致潜在的不良表型"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在不良反应可能抵消益处"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在不良反应可能抵消益处"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在不良反应可能抵消益处"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在不良反应可能抵消益处"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在不良反应可能抵消益处"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在不良反应可能抵消益处"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在不良反应可能抵消益处"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在不良反应可能抵消益处"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在不良反应可能抵消益处"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在不良反应可能抵消益处"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在不良反应可能抵消益处"
        },
        {
          "source": "n_adverse_phenotype",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在不良反应可能抵消益处"
        }
      ],
      "conflict_hotspots": [
        {
          "topic": "drug_efficacy_vs_adverse_effects",
          "pro_nodes": [
            "n_fibrate",
            "n_niacin",
            "n_omega_3",
            "n_statin",
            "n_ezetimibe",
            "n_insulin",
            "n_lipid_lowering",
            "n_oral_hypoglycemics",
            "n_metformin",
            "n_gemfibrozil",
            "n_fenofibrate",
            "n_atorvastatin"
          ],
          "con_nodes": [
            "n_adverse_phenotype"
          ],
          "note": "在治疗高甘油三酯血症时，疗效和险反应可能发生冲突"
        }
      ]
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "不同药物可能通过不同机制导致不良反应",
        "confidence": "high"
      },
      {
        "id": "K2",
        "text": "缺乏针对性对照研究以支持疗效和安全性声明",
        "confidence": "medium"
      }
    ],
    "assumptions_challenged": [
      "药物的作用机制是否直接作用于高甘油三酯症的核心病理",
      "药物使用后的不良反应是否被充分评估"
    ],
    "falsification_tests": [
      "是否有数据证明特定药物在安全性方面超出预期",
      "是否存在系统综述或随机对照试验显示反应与纤维素类药物有效性相比的风险"
    ],
    "next_focus_for_pi": [
      "要求提供不同类别药物的比较研究以评估疗效与不良反应之平衡",
      "针对冲突热点进行深入讨论和文献支持"
    ]
  }
}